ALGERT GLOBAL LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 296 filers reported holding HAEMONETICS CORP in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$2,225
+115.2%
24,837
+104.5%
0.10%
+133.3%
Q2 2023$1,034
-67.0%
12,147
-67.9%
0.04%
-69.6%
Q1 2023$3,134
-99.6%
37,879
+228.7%
0.15%
+184.6%
Q3 2022$853,000
-3.7%
11,524
-15.2%
0.05%
-22.4%
Q2 2022$886,000
-3.4%
13,587
-6.3%
0.07%
+11.7%
Q1 2022$917,000
+25.1%
14,497
+4.8%
0.06%
-34.8%
Q4 2021$733,000
-14.4%
13,829
+14.0%
0.09%
-19.3%
Q3 2021$856,00012,1290.11%
Other shareholders
HAEMONETICS CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders